IL33 and allergic asthma: This point of view may have been triggered by the use of robust ILC2 induction models, such as administration of IL-25, IL-33, papain, and Alternaria to study these cells in the context of allergic asthma or dermatitis (15, 16, 18, 19, 61, 62).